1-63323323-G-A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012183.3(FOXD3):c.265G>A(p.Gly89Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,360,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G89E) has been classified as Uncertain significance.
Frequency
Consequence
NM_012183.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXD3 | NM_012183.3 | c.265G>A | p.Gly89Arg | missense_variant | Exon 1 of 1 | ENST00000371116.4 | NP_036315.1 | |
FOXD3-AS1 | NR_121636.1 | n.185+168C>T | intron_variant | Intron 1 of 2 | ||||
FOXD3-AS1 | NR_121637.1 | n.87+1032C>T | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000129 AC: 19AN: 147414Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 16266 AF XY: 0.00
GnomAD4 exome AF: 0.00000660 AC: 8AN: 1213034Hom.: 0 Cov.: 33 AF XY: 0.00000340 AC XY: 2AN XY: 588616 show subpopulations
GnomAD4 genome AF: 0.000129 AC: 19AN: 147414Hom.: 0 Cov.: 32 AF XY: 0.000152 AC XY: 11AN XY: 72156 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.265G>A (p.G89R) alteration is located in exon 1 (coding exon 1) of the FOXD3 gene. This alteration results from a G to A substitution at nucleotide position 265, causing the glycine (G) at amino acid position 89 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at